Nomura Asset Management International’s Xenon Pharmaceuticals XENE Stock Holding History

Nomura Asset Management International’s Portfolio XENE Stock Details XENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.3M	Buy	54,656 +7,615	+16%	+$423K	0.01%	940
2026 Q1	$2.73M	Sell	47,041 -916	-2%	-$42.2K	﹤0.01%	906
2025 Q4	$2.15M	Buy	+47,957	New	+$2.01M	﹤0.01%	985

Other funds holding XENE

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Nomura Asset Management International's XENE Position: Q2 2026 in Review

Nomura Asset Management International increased its Xenon Pharmaceuticals (XENE) stake by 16% in Q2 2026, buying an estimated $423K and bringing the position to 54,656 shares worth $3.3M. The position accounts for 0.01% of the portfolio, ranked #940.

Nomura Asset Management International first reported a position in XENE in Q4 2025 and has held it in 3 quarters since. 315 funds tracked by Wall St. Rank hold XENE as of Q2 2026.

Nomura Asset Management International held 54,656 shares of Xenon Pharmaceuticals worth $3.3M as of Q2 2026.
Nomura Asset Management International bought 7,615 Xenon Pharmaceuticals shares in Q2 2026, an estimated $423K.
Xenon Pharmaceuticals made up 0.01% of Nomura Asset Management International's portfolio in Q2 2026, its #940 holding.
Nomura Asset Management International first reported a position in Xenon Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
315 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.

Based on Nomura Asset Management International's 13F filing for Q2 2026, filed 14 Aug 2026.